Wound Care solutions
|

Procurement’s role in reducing the total cost of wound care

Seek partnership, not just products, for a strategic mix of high-performing solutions, clinician support and health-economic insights.

A McKinsey & Company survey found that 44% of hospital executives in Europe and the U.S. are working more closely with Medtech as industry partners 4 . McKinsey’s report indicates that healthcare leaders are growing more aware of the supplier’s role in not only containing treatment costs, but also improving quality of care4.

A collaborative approach brings experts to the table who can evaluate, configure and implement a tailored programme focused on your unique challenges and opportunities.

For example, Mölnlycke Health Care demonstrates the strength of 'beyond product' partnerships in the wound care space. One client, the largest rural hospital in the United States, sought Mölnlycke’s help to reduce redundancies that caused less-than-desired clinical outcomes and excessive product usage (an average USD620,000 annual expenditure) 5. Mölnlycke coordinated a wound care standardisation programme that included inventory analysis, protocol assessment and clinical education across the wound care continuum. The results included a near 40% improvement in wound healing rates, $300,000 annual reduction in supply expenses, and increased patient and clinician satisfaction 5 .

A wound care standardisation programme implemented at US hospital achieved

Our programme is not something we just introduce and hand over for you to implement. It’s a customer-focused process that brings together patient-centric solutions, services and tools that simplify and standardise outcomes delivery and make value easier to calculate. We walk through the journey with you every step of the way. We lead the needs assessment process to clarify the best opportunities for improvement and value creation based on your current state.

Working together, we develop an improvement plan — including ways to collect data — that aligns to your desired outcomes and financial goals. Our clinical experts support your clinical teams directly with education, training and tools that are delivered in both hands-on and digital formats.

We also closely monitor programme success to not only ensure goals are being met, but to also identify where adjustments can be made to maximise results.

    1. Boston Consulting Group, “How Procurement Unlocks Value-Based Health Care,” 9 January 2020
    2. Guest JF, Fuller GW, Vowden P. Cohort study evaluating the burden of wounds to the UK’s National Health Service in 2017/2018: update from 2012/2013. BMJ Open 2020;10:e045253. doi:10.1136/ bmjopen-2020-045253
    3. Markets and Markets, “Advanced Wounds Care by Product, Wound Type, End User. Global Forecast to 2026.
    4. McKinsey & Company, “Creating ‘beyond the product’ partnerships between providers and medtech players,” February 2019
    5. McNees, P and Kueven, JA. The Bottom Line on Wound Care Standardization. Healthcare Financial Management. March 2011
    6. Welsh L. Wound care evidence, knowledge and education amongst nurses: a semi-systematic literature review. Int Wound J 2018; 15:53–61
    7. Tayyib, Nahla & Ramaiah, Pushpamala. (2021). Nurses’ Challenges in Wound Care Management- A Qualitative Study. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 15. 10.7860/JCDR/2021/47039.14626.
    8. Kotler Marketing MedTech Analysis, “Hospital Purchasing and Value Analysis Evolve: Implications for Suppliers,” 2018
    9. Becker’s Hospital Review and Mölnlycke Health Care, “Wound care standardization: How it drives clinical and financial outcomes — and total value,” November 2, 2022
    10. Joergensen B, Åberg Håkansson M. CHEXU 03, A randomised multi-centre non-inferiority investigation to evaluate the efficacy and safety of Exufiber versus Aquacel Extra in moderately or strongly exuding venous and mixed ulcers of predominantly venous origin; Mölnlycke Clinical Investigation Report. PD-581107 Rev 00. 2020
    11. Lev-Tov H, Picchietti A. Exufiber Ag+01; A clinical investigation to study the effect of Exufiber Ag+ and other gelling fibre dressings on wound exudate and bioburden in medium to high exuding wounds; Mölnlycke Clinical Investigation Report. PD-573989 Rev 01. 2019.
    12. Zarghooni K, et al. Is the use of modern versus conventional wound dressings warranted after primary knee and hip arthroplasty? Acta Orthop Belg. 2015;81(4):768-775.
    13. Mazuz, R. “4 Ways to Integrate Digital Health into the Wound Center Today,” Today’s Wound Clinic, April 2019